Rare Variants in 48 Genes Account for 42% of Cases of Epilepsy With or Without Neurodevelopmental Delay in 246 Pediatric Patients
暂无分享,去创建一个
F. Ramos | O. Moldovan | M. Couce | Montserrat Rodríguez-Pedreira | F. Laranjeira | A. Fernández-Marmiesse | Felícitas Díaz-Flores | A. Fontalba | A. Camacho | S. Ibáñez-Micó | M. Ruiz-Falcó | Margarita Martínez-Atienza | A. Pérez‐Cejas | Carmen Benito | V. Cantarín | M. Pérez-Poyato | L. Gutiérrez-Solana | Rocío Calvo | P. Quijada | Sofia Quintans | R. Simón | Iria Roca | B. Felgueroso | Mª Rosario Domingno | Mª Llanos Carrasco | M. Carrasco | Felicitas Díaz-Flores | A. Fernández‐Marmiesse
[1] M. Couce,et al. PattRec: An easy-to-use CNV detection tool optimized for targeted NGS assays with diagnostic purposes. , 2020, Genomics.
[2] A. El-Hattab,et al. West syndrome, developmental and epileptic encephalopathy, and severe CNS disorder associated with WWOX mutations. , 2018, Epileptic disorders : international epilepsy journal with videotape.
[3] C. Zai,et al. Novel and de novo mutations in pediatric refractory epilepsy , 2018, Molecular Brain.
[4] E. Farrow,et al. Incidental diagnosis of tuberous sclerosis complex by exome sequencing in three families with subclinical findings , 2018, neurogenetics.
[5] S. Traynelis,et al. A novel missense mutation in GRIN2A causes a nonepileptic neurodevelopmental disorder , 2018, Movement disorders : official journal of the Movement Disorder Society.
[6] R. Miles,et al. Second-hit mosaic mutation in mTORC1 repressor DEPDC5 causes focal cortical dysplasia–associated epilepsy , 2018, The Journal of clinical investigation.
[7] M. Couce,et al. Prioritization of Variants Detected by Next Generation Sequencing According to the Mutation Tolerance and Mutational Architecture of the Corresponding Genes , 2018, International journal of molecular sciences.
[8] R. Rosch,et al. Incorporating epilepsy genetics into clinical practice: a 360°evaluation , 2018, npj Genomic Medicine.
[9] A. Fattal-Valevski,et al. Detection of copy number variations in epilepsy using exome data , 2018, Clinical genetics.
[10] S. Baulac,et al. Review: Mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy , 2018, Neuropathology and applied neurobiology.
[11] L. Vissers,et al. Identification of rare de novo epigenetic variations in congenital disorders , 2018, bioRxiv.
[12] A. Bassett,et al. Prevalence of Pathogenic Copy Number Variation in Adults With Pediatric-Onset Epilepsy and Intellectual Disability , 2017, JAMA neurology.
[13] Amanda S. Lindy,et al. High frequency of mosaic pathogenic variants in genes causing epilepsy-related neurodevelopmental disorders , 2017, Genetics in Medicine.
[14] A. Grottesi,et al. Lethal digenic mutations in the K+ channels Kir4.1 (KCNJ10) and SLACK (KCNT1) associated with severe-disabling seizures and neurodevelopmental delay. , 2017, Journal of neurophysiology.
[15] G. Mancini,et al. Male patients affected by mosaic PCDH19 mutations: five new cases , 2017, neurogenetics.
[16] H. Lerche,et al. The role of genetic testing in epilepsy diagnosis and management , 2017, Expert review of molecular diagnostics.
[17] J. Kearney,et al. Cacna1g is a genetic modifier of epilepsy in a mouse model of Dravet syndrome , 2017, Epilepsia.
[18] A. Fatemi,et al. FOXG1 syndrome: genotype–phenotype association in 83 patients with FOXG1 variants , 2017, Genetics in Medicine.
[19] Dong Seok Kim,et al. Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia. , 2017, American journal of human genetics.
[20] R. Guerrini,et al. The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients , 2017, Molecular Diagnosis & Therapy.
[21] G. Cooper,et al. Germline and somatic mutations in the MTOR gene in focal cortical dysplasia and epilepsy , 2016, Neurology: Genetics.
[22] J. García-Peñas,et al. Clinical and genetic features of 13 Spanish patients with KCNQ2 mutations , 2016, Journal of Human Genetics.
[23] Arthur P. Grollman,et al. Genome-wide quantification of rare somatic mutations in normal human tissues using massively parallel sequencing , 2016, Proceedings of the National Academy of Sciences.
[24] Beth K. Martin,et al. Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism. , 2016, JAMA neurology.
[25] Jae Seok Lim,et al. Brain somatic mutations in MTOR leading to focal cortical dysplasia , 2016, BMB reports.
[26] D. Pinto,et al. Identification of novel genetic causes of Rett syndrome-like phenotypes , 2016, Journal of Medical Genetics.
[27] J. Conroy,et al. Unexplained early onset epileptic encephalopathy: Exome screening and phenotype expansion , 2016, Epilepsia.
[28] G. Carvill,et al. Mutations in KCNT1 cause a spectrum of focal epilepsies , 2015, Epilepsia.
[29] H. Kitaura,et al. Somatic Mutations in the MTOR gene cause focal cortical dysplasia type IIb , 2015, Annals of neurology.
[30] Heather C Mefford,et al. Copy Number Matters in Epilepsy , 2015, Epilepsy currents.
[31] Michael R. Johnson,et al. Copy number variant analysis from exome data in 349 patients with epileptic encephalopathy , 2015, Annals of neurology.
[32] B. Li,et al. The SCN1A Mutation Database: Updating Information and Analysis of the Relationships among Genotype, Functional Alteration, and Phenotype , 2015, Human mutation.
[33] R. Weksberg,et al. Diagnostic yield of genetic testing in epileptic encephalopathy in childhood , 2015, Journal of the Neurological Sciences.
[34] Seok-Gu Kang,et al. Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy , 2015, Nature Medicine.
[35] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[36] Epilepsy Phenome,et al. De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. , 2014, American journal of human genetics.
[37] G. McVean,et al. Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications , 2014, Nature Genetics.
[38] S. Noachtar,et al. Exonic microdeletions of the gephyrin gene impair GABAergic synaptic inhibition in patients with idiopathic generalized epilepsy , 2014, Neurobiology of Disease.
[39] P. Awadalla,et al. Genetically encoded impairment of neuronal KCC2 cotransporter function in human idiopathic generalized epilepsy , 2014, EMBO reports.
[40] I. Scheffer,et al. A variant of KCC2 from patients with febrile seizures impairs neuronal Cl− extrusion and dendritic spine formation , 2014, EMBO reports.
[41] Peter Donnelly,et al. Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis , 2014, Human molecular genetics.
[42] Michael R. Johnson,et al. De novo mutations in the classic epileptic encephalopathies , 2013, Nature.
[43] C. Walsh,et al. Somatic Mutation, Genomic Variation, and Neurological Disease , 2013, Science.
[44] M. Spielmann,et al. CNVs of noncoding cis-regulatory elements in human disease. , 2013, Current opinion in genetics & development.
[45] S. Scherer,et al. Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizures. , 2013, Human molecular genetics.
[46] A. Brooks-Kayal,et al. Down‐regulation of gephyrin and GABAA receptor subunits during epileptogenesis in the CA1 region of hippocampus , 2013, Epilepsia.
[47] Holger Lerche,et al. Rare exonic deletions of the RBFOX1 gene increase risk of idiopathic generalized epilepsy , 2013, Epilepsia.
[48] H. Mefford,et al. Exon‐disrupting deletions of NRXN1 in idiopathic generalized epilepsy , 2013, Epilepsia.
[49] P. Genton,et al. PRRT2 links infantile convulsions and paroxysmal dyskinesia with migraine , 2012, Neurology.
[50] L. Kaczmarek,et al. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy , 2012, Nature Genetics.
[51] Bradley P. Coe,et al. A genetic model for neurodevelopmental disease , 2012, Current Opinion in Neurobiology.
[52] Data production leads,et al. An integrated encyclopedia of DNA elements in the human genome , 2012 .
[53] Meredith Wilson,et al. The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy , 2012, European Journal of Human Genetics.
[54] S. Gallati,et al. Targeted next generation sequencing as a diagnostic tool in epileptic disorders , 2012, Epilepsia.
[55] ENCODEConsortium,et al. An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.
[56] Pablo Cingolani,et al. © 2012 Landes Bioscience. Do not distribute. , 2022 .
[57] J. Jankovic,et al. Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. , 2012, Cell reports.
[58] I. Scheffer,et al. Rare copy number variants are an important cause of epileptic encephalopathies , 2011, Annals of neurology.
[59] Caleb Davis,et al. Exome Sequencing of Ion Channel Genes Reveals Complex Profiles Confounding Personal Risk Assessment in Epilepsy , 2011, Cell.
[60] A. Gonzalez-Perez,et al. Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. , 2011, American journal of human genetics.
[61] Melinda S. Martin,et al. Neuronal voltage-gated ion channels are genetic modifiers of generalized epilepsy with febrile seizures plus , 2011, Neurobiology of Disease.
[62] Serafim Batzoglou,et al. Identifying a High Fraction of the Human Genome to be under Selective Constraint Using GERP++ , 2010, PLoS Comput. Biol..
[63] Kate M. Lawrence,et al. Timing of de novo mutagenesis--a twin study of sodium-channel mutations. , 2010, The New England journal of medicine.
[64] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[65] Michael R. Johnson,et al. Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. , 2010, American journal of human genetics.
[66] Tomas W. Fitzgerald,et al. Origins and functional impact of copy number variation in the human genome , 2010, Nature.
[67] Aaron R. Quinlan,et al. BIOINFORMATICS APPLICATIONS NOTE , 2022 .
[68] I. Scheffer,et al. Familial and sporadic 15q13.3 microdeletions in idiopathic generalized epilepsy: precedent for disorders with complex inheritance. , 2009, Human molecular genetics.
[69] Ken Chen,et al. VarScan: variant detection in massively parallel sequencing of individual and pooled samples , 2009, Bioinform..
[70] Christian E Elger,et al. CLCN2 variants in idiopathic generalized epilepsy , 2009, Nature Genetics.
[71] Kai Ye,et al. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads , 2009, Bioinform..
[72] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[73] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[74] C. Béroud,et al. Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.
[75] H. Lerche,et al. Two novel CLCN2 mutations accelerating chloride channel deactivation are associated with idiopathic generalized epilepsy , 2009, Human Mutation.
[76] Christian E Elger,et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy , 2009, Nature Genetics.
[77] C. Depienne,et al. Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients , 2008, Journal of Medical Genetics.
[78] A. Konagaya,et al. Microchromosomal deletions involving SCN1A and adjacent genes in severe myoclonic epilepsy in infancy , 2008, Epilepsia.
[79] Jing Qian,et al. Masking epilepsy by combining two epilepsy genes , 2007, Nature Neuroscience.
[80] E. Bertini,et al. Familial Occurrence of Febrile Seizures and Epilepsy in Severe Myoclonic Epilepsy of Infancy (SMEI) Patients with SCN1A Mutations , 2006, Epilepsia.
[81] E. Bertini,et al. Somatic and germline mosaicisms in severe myoclonic epilepsy of infancy. , 2006, Biochemical and biophysical research communications.
[82] K. Yamakawa,et al. A missense mutation in SCN1A in brothers with severe myoclonic epilepsy in infancy (SMEI) inherited from a father with febrile seizures , 2005, Brain and Development.
[83] H. Oguni,et al. Mutations of Neuronal Voltage‐gated Na+ Channel α1 Subunit Gene SCN1A in Core Severe Myoclonic Epilepsy in Infancy (SMEI) and in Borderline SMEI (SMEB) , 2004, Epilepsia.
[84] Federico Zara,et al. Familial severe myoclonic epilepsy of infancy: truncation of Nav1.1 and genetic heterogeneity. , 2003, Epileptic disorders : international epilepsy journal with videotape.
[85] T. Wienker,et al. Genome search for susceptibility loci of common idiopathic generalised epilepsies. , 2000, Human molecular genetics.
[86] A. Fatemi,et al. FOXG 1 syndrome : genotype – phenotype association in 83 patients with FOXG 1 variants , 2017 .
[87] Michael R. Johnson,et al. De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. , 2014, American journal of human genetics.
[88] S. Baulac. mTOR signaling pathway genes in focal epilepsies. , 2016, Progress in brain research.
[89] De novo mutations in epileptic encephalopathies , 2013 .
[90] C. Baker,et al. Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. , 2010, Brain : a journal of neurology.
[91] S. Horvath,et al. Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies , 2003, Nature Genetics.
[92] K. Shadan,et al. Available online: , 2012 .